AdaptHealth Corp.
AHCOHealthcareNASDAQMedical Devices
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. With a market capitalization of $1.49B, it sits in small-cap territory. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Market Cap
$1.49B
Beta
1.45
P/E (TTM)
—
P/E (Fwd)
9.33
EPS (TTM)
$-0.59
EPS (Fwd)
$1.17
ROE
-4.9%
ROA
2.6%
Cash
$48.0M
Total Debt
$2.00B
Free CF
$267.9M
52W Change
18.9%
Annual Financials
Cash vs Debt
On the balance sheet, AHCO has $48.0M in cash with $2.00B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $267.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -4.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.6% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.97B (2022) to $3.24B (2025).
AdaptHealth Corp. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AHCO.